Skip to main content

Table 1 Demographic and clinical data of septic shock and non-septic patients

From: High-density lipoprotein (HDL) particle size and concentration changes in septic shock patients

 

Septic shock (n = 20)

Control (n = 20)

P

Age [years (Q1–Q3)]

68 (59.2–76.7)

70.5 (54.2–75.5)

0.65

Male [n (%)]

17 (85)

13 (65)

0.14

BMI [kg/m2 (Q1–Q3)]

24.70 (20.2–28.6)

25 (20.2–30.5)

0.65

Dyslipidemia [n (%)]

5 (25)

3 (15)

0.69

Statin medication [n (%)]

3 (15)

0 (0)

0.23

SAPSII (Q1–Q3)

39 (29–59.5)

38 (30–51)

0.73

SOFA score (Q1–Q3)

8 (8–10)

6 (4–8)

< 0.001

Mechanical ventilation [n (%)]

20 (100)

14 (70)

0.02

Need for norepinephrine [n (%)]

20 (100)

11 (55)

0.001

Norepinephrine (micg/kg/min)

0.42 (0.31–0.64)

0.12 (0.0–0.27)

< 0.001

Enteral nutrition [n (%)]

12 (60)

18 (90)

0.065

Parenteral nutrition [n (%)]

5 (25)

2 (10)

0.41

Diagnosis at admission [n (%)]

 Peritonitis

10 (50)

 Pneumonia

5 (25)

 Cellulitis

2 (10)

 Arthritis

1 (5)

 Hepatic abscess

1 (5)

 Trauma

6 (30)

 Intracerebral hemorrhage

6 (30)

 Traumatic brain injury

5 (25)

 Hemorrhagic shock

2 (10)

  1. Results are expressed as medians (IQR). Between-group differences were analyzed by a Mann–Whitney test, and a Chi-square test